Evidence map›Paper›PMID 15975090›Full record

ArticleThe Biochemical journal2005

Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin.

Leann K Massey, Alex L Mah, Mervyn J Monteiro

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer's disease risk.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Protein aggregation and degradation mechanisms in neurodegenerative diseases.American journal of neurodegenerative disease · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. MUC1 is a substrate for gamma-secretase.Journal of cellular biochemistry · 2009
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Leann K MasseyMolecular and Cell Biology Graduate Program, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA.
Alex L Mah
Mervyn J Monteiro
University of Maryland, Baltimore · US

Funding

FUNCTION OF ALZHEIMER DISEASE PRESENILIN 2R01AG016839 · NIA · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MONTEIRO, MERVYN J · 2000 to 2009
$2.7M
Functional Studies of UbiquilinR01GM066287 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MONTEIRO, MERVYN J · 2003 to 2011
$2.5M
NIA NIH HHS AG016839NIA NIH HHS R01 AG016839NIGMS NIH HHS GM066287NIGMS NIH HHS R01 GM066287
6 · The paper itself

Abstract

Mutations in presenilin proteins (PS1 and PS2) lead to early-onset Alzheimer's disease. PS proteins are endoproteolytically cleaved into two main fragments: the NTF (PS N-terminal fragment) and the CTF (PS C-terminal fragment). The two fragments are believed to constitute the core catalytic enzyme activity called gamma-secretase, which is responsible for cleaving beta-amyloid precursor protein to release Abeta. Thus, studying factors that modulate PS fragment levels could provide important information about gamma-secretase. Previously, we demonstrated that the protein, ubiquilin-1, interacts both in vivo and in vitro with PS and that overexpression of ubiquilin-1 or -2 leads to increased accumulation of full-length PS proteins. Using wild-type HEK-293 cells (human embryonic kidney 293 cells) and PS-inducible cells, we now show that overexpression of either ubiquilin-1 or -2 decreases the PS NTF and CTF levels. Conversely, siRNA (small interfering RNA)-mediated knockdown of ubiquilin-1 and -2 proteins increased the PS NTF and CTF levels. We considered that ubiquilin might alter PS fragment accumulation by acting as a shuttle factor escorting PS fragments to the proteasome for degradation. However, through proteasome inhibition studies, we show that this does not occur. Instead, our results suggest that ubiquilin regulates PS fragment production. We also examined whether other components of the gamma-secretase complex are affected by ubiquilin expression. Interestingly, overexpression of ubiquilin resulted in a decrease in Pen-2 and nicastrin levels, two essential components of the gamma-secretase complex. In contrast, knockdown of ubiquilin-1 and -2 protein expression by RNAi (RNA interference) increased Pen-2 and nicastrin levels. Finally, we show that inhibition of the proteasome results in decreased PS fragment production and that reversal of proteasome inhibition restores PS fragment production, suggesting that the proteasome may be involved in PS endoproteolysis. These studies implicate ubiquilin as an important factor in regulating PS biogenesis and metabolism.

Indexed as

Adaptor Proteins, Signal TransducingAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsCell LineEndopeptidasesGene Expression Regulation, EnzymologicHumansMembrane GlycoproteinsMembrane ProteinsPeptide FragmentsPresenilin-1Presenilin-2Proteasome Endopeptidase ComplexAdaptor Proteins, Signal TransducingAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesAutophagy-Related ProteinsBACE1 protein, humanCarrier ProteinsCell Cycle ProteinsEndopeptidasesMembrane GlycoproteinsMembrane Proteinsnicastrin proteinPeptide FragmentsPresenilin-1Presenilin-2Proteasome Endopeptidase ComplexPSEN1 protein, humanPSEN2 protein, humanPSENEN protein, humanUbiquitinsUBQLN1 protein, humanUBQLN2 protein, human

Identifiers

PMID15975090
PMCPMC1276952
OpenAlexW2038114557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.